Correction of Antithrombogenic Activity of the Vascular Wall and Insulin Provision in Patients with Ischemic Heart Disease

Abstract

The antithrombogenic activity of the vascular wall during probe, insulin provision during the glucosotolerant test are studied in 50 patients with ischemic heart disease and in 18 healthy persons. The change of antiagregational, anticoagulant, fibrinolytic activity of the endothelial cells of the vascular wall is revealed. The essential hyperinsulinemia duruing the whole glucosotolerant test at the low level of C-peptide showing the disorder of transforming proinsulin into insulin is noted. The use of ticlide is recommended in combined treatment of patients with ischemic heart disease

 

Keywords

Kazan Medical archive

References

[1] Габбасов В.А., Попов Е.Г., Гаврилов Е.Я. и соавт. //Билл. эксп. биол. — 1989. — № 10. — С. 437—440.

[2] Соколов Е.И. Сахарный диабет и атеросклероз. — М., 1996.

[3] Becker R. С.//Cardiology. — 1993. — Vol. 79. — P. 265 - 270.

[4] Bonne C., Martin B.//Thromb. And Haemost. — 1981.-Vol. 46.-P. 67.

[5] Cannon R. O., Camici P.// Circulation. — 1992. — Vol. 85. - P. 883 - 892.

[6] Stout R. W. Hormones and Atherosclerosis. - Boston, 1982.

[7] Valid E., Maffrand J. et al.// Agents Actions. — 1984.- Suppl. 15.-P. 50-59.

RIGHTS & PERMISSIONS

Altshuler M.Y., Sazhina E.Y.